Biomedical pumping solutions for a
Brighter future
Change is needed
The medical industry requires the next generation of pump technology to solve the problems inherent in supporting blood flow.
Solving these problems will lessen the economic burden, improve quality of life to those already receiving this type of therapy and greatly broaden the scope of treatable conditions.
Through the application of Astronova's unique positive displacement pump technology we are creating novel solutions for cardiovascular circulatory support and other blood or biofluid applications.
Advanced flow technology
Astronova has developed a very unique, proprietary positive displacement pump specifically for cardiac assist and circulatory support in the medical field.
The Astronova Blood Pump will be a very low speed (RPM), self priming, high output, rotary, positive displacement pump. This category of pump, to our knowledge, has not been used in the medical device field, to date.
Growing market
Cardiovascular disease
Cardiovascular disease is the leading cause of death, accounting for 17.6 million deaths per year, thats 31% of all global deaths.
Biomedical pump market
The biomedical pumping market is a $30 Billion dollar industry and rapidly growing.
Rapidly growing
The need for biomedical pumps is forever and rapidly expanding to treat a magnitude of conditions and support blood flow.
Novel solutions to address clinical problems
Renal Perfusion
Cardiorenal Syndrome is a large and growing unmet clinical need. This pumping technology will aim to rest the heart by reducing the cardiac workload while perfusing the kidneys.
Critical Limb Ischemia
CLI is a rapidly increasing condition with a limb being amputated every 2 minutes. This requires a new look at the treatment methods, to increase patients quality of life by hyper perfusing the limb and reducing the need for amputation.
Ventricular assist
Cardiovascular disease is the leading cause of death globally with 1 in 5 adults developing heart failure in their lifetime. There is a growing demand for ventricular assist devices to support cardiac output.